Enzymatica AB (publ)

OM:ENZY Stock Report

Market Cap: SEK 321.5m

Enzymatica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:ENZY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Nov 24BuySEK 54,313Louise NicolinIndividual30,610SEK 1.78
14 Nov 24BuySEK 85,906Louise NicolinIndividual47,543SEK 1.81
11 Nov 24BuySEK 93,389Louise NicolinIndividual50,794SEK 1.87
07 Nov 24BuySEK 44,600Therese FilmerssonIndividual25,000SEK 1.78
16 Sep 24BuySEK 117,000Bengt BaronIndividual45,000SEK 2.60
29 Apr 24SellSEK 200,734Gudmundur PalmasonIndividual68,300SEK 2.94
26 Apr 24SellSEK 444,205Gudmundur PalmasonIndividual142,000SEK 3.18
25 Mar 24SellSEK 60,308Gudmundur PalmasonIndividual19,226SEK 3.18
23 Feb 24SellSEK 900,001Gudmundur PalmasonIndividual300,000SEK 3.00

Insider Trading Volume

Insider Buying: ENZY insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ENZY?
Owner TypeNumber of SharesOwnership Percentage
Institutions32,9050.0153%
Individual Insiders45,707,32721.2%
General Public170,029,15478.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 31.4%.

Top Shareholders

Top 11 shareholders own 21.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.9%
Mats Andersson
36,398,195SEK 54.2m0%no data
2.08%
Gudmundur Palmason
4,497,097SEK 6.7m-51.7%no data
1.65%
Bengt Baron
3,552,859SEK 5.3m1.28%no data
0.19%
Therese Filmersson
400,000SEK 596.0k6.67%no data
0.13%
Claus Egstrand
279,453SEK 416.4k0%no data
0.11%
Louise Nicolin
228,947SEK 341.1k129%no data
0.11%
Helene Willberg
228,753SEK 340.9k0%no data
0.039%
Claes Molin
85,023SEK 126.7k0%no data
0.017%
Chris Czyrko
37,000SEK 55.1k0%no data
0.0084%
Elite Fund Management Ltd
18,140SEK 27.0k0%0.02%
0.0068%
FCG Fonder AB
14,765SEK 22.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 19:33
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Enzymatica AB (publ) is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
Peter SelleiPenser Access
Maria Karlsson OsipovaPenser Access